SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹124 Cr | ₹97 Cr | ₹43 Cr | ₹26 Cr | ₹41 Cr |
What is the latest Total Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹41 Cr |
How is Total Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | 28.19 | |
| Mar2024 | ₹97 Cr | 125.18 | |
| Mar2023 | ₹43 Cr | 68.27 | |
| Mar2022 | ₹26 Cr | -37.54 | |
| Mar2021 | ₹41 Cr | - | |
Compare Total Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹186.5 Cr | -8.3% | 11.7% | -38.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -8.3% |
11.7% |
-38.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses